Clinical Outcomes of Utilization of Stress Ulcer Prophylaxis
in Hospitalized, Non-ICU Patients
Paige Robinson, DO, PGY-2 and Kate Radvansky, DO

BACKGROUND

PROTOCOL
All Hospitalized Patients
to General Medical Floor

Goal
This study is a retrospective chart review that aims to measure the effect of stress
ulcer prophylaxis in hospitalized non-ICU level patients to determine the clinical
effect of the presence or absence of stress ulcer prophylaxis.

Definition, Pathogenesis, Incidence of Stress Ulcers

Definition
Superficial ulceration, erosion of gastric mucosa

DISCUSSION

Excluded:

Patients with Clinically Important Bleeding Events

Home regimen includes
prophylactic medication

Patient #4

Underuse of Prophylaxis
Risk factors: male, NSAID
and steroid, AKI, sepsis
– Event: Transfusion, Scope
Patient #2

Correct use of Prophylaxis
Risk factors: age, male, AKI,
liver disease
– Event: Transfusion, ICU
Upgrade, Death
Patient #5

–
–

Initiated on prophylactic
medication for
therapeutic purpose
(GI Bleed, GERD, etc.)

Underuse of Prophylaxis
Risk factors: age, male,
anticoagulation
– Event: Overt GI bleeding
Patient #3
–
–

Most commonly in stomach, but can occur in duodenum or esophagus

Included: all remaining patients

Pathogenesis1-3

Patient #1

Acid hyper secretion (especially neurologic and thermal injuries) due to excess
gastric stimulation of parietal cells
Also stimulated by stress-triggered vagal stimulation

–
–

Pro-inflammatory state causes release of mediators: arachidonic acid
metabolites, cytokines, oxygen free radicals

–

Underuse of Prophylaxis
Risk factors: age, male, DAPT,
AKI
Event: Transfusion

–
–

Correct use of Prophylaxis
Risk factors: age, male,
anticoagulation
– Event: scope
Patient #6
–
–

–
–
–

Correct use of Prophylaxis
Risk factors: AKI
Event: Transfusion

Impaired mucosal protection
Decreased perfusion

Underuse

Increased concentration of refluxed bills salts and uremic toxins

+ risk factors
no prophylaxis

Synthesis decreased due to poor gut perfusion from shock, sepsis, trauma
Start proximally in the acid-secreting portion of stomach, then progresses: over
time, become deeper and move distally

Incidence4-7

• Anticoagulation +/- antiplatelet agent
• NSAID and corticosteroid
• Dual Antiplatelet Therapy (DAPT)
• Sepsis

Definition of Clinically Important Bleeding
• Transfusion
• Endoscopic Evaluation or Intervention

CONCLUSION
There is no statistically significant difference in clinically important
bleeding based on correct or incorrect use of stress ulcer prophylaxis in
hospitalized, non-ICU patients. This is consistent with previous
literature. Use of stress ulcer prophylaxis on floor patients remains
individualized by the clinician, who must give consideration to the
specific patient and risk factors present. Further studies are needed to
determine if a certain number or combination of risk factors is
significant rather than individual risk factors.
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Independent Risk Factors for Stress Ulcer Formation1,8

• Overt GI Bleeding

no risk
factors
+ prophylaxis

100%

*Depending on study, definition of clinically important bleeding, or risk factors
present

• ICU Upgrade

+ risk factors
+ prophylaxis

RESULTS: RATES OF BLEEDING

Range: 0.005% to 7.85%

• Perforation or Surgical Intervention

Overuse

Analysis: Rates of clinically important bleeding per group?

Wedge-shaped mucosal hemorrhages with necrosis of superficial mucosal cells; if
progresses to submucosa, can cause significant and life-threatening bleeding

• Age >60
• Male
• Liver disease
• Acute renal failure (AKI)

Correct Use
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Figure 1. Percent of patients with clinically important bleeding (CIB) based
on the use of stress ulcer prophylaxis. Three of 190 patients in the underuse
category had clinically important bleeding events. Three of 46 patients with correct use
of prophylaxis had events. The result of an ANOVA was p = 0.156, conferring no
statistical significance.
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